Researchers at the University of Florida found that combining the chemotherapy drug temozolomide with a small molecule inhibitor of DNA polymerase beta was more effective at reducing tumor growth in colon cancer than temozolomide alone. Temozolomide is an oral chemotherapy drug commonly used to treat colon cancer that attaches alkyl groups to DNA, damaging it. However, cancer cells have mechanisms to repair this DNA damage. The small molecule inhibitor was designed to disrupt these repair mechanisms and thus make the chemotherapy more effective. When combined, the reduction in tumor growth was higher than with chemotherapy alone.